Supply of Brincidofovir Oral Suspension (Tembexa)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This subcontract involves the supply of 2,000 bottles of Brincidofovir Oral Suspension, known as Tembexa, to prime contractors supporting the Department of Defense Medical Supply Chain. The selected provider is responsible for ensuring the drug is provided in specified quantities, utilizing pharmaceutical-grade packaging, and coordinating all shipments to designated DLA receiving points in Bethesda. To be eligible, the provider must maintain valid pharmaceutical wholesaler or distributor licensing and ensure the product has full FDA approval. This procurement falls under NAICS code 423450 and is managed by the Medical Supply Chain Pharm FSA.
General Info
Place of Performance
BETHESDA, MD, 20889-5600, USASet-Aside
Documents
This scope was carved out of SPE2DP-27-T-0212.
The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.
BRINCIDOFOVIR ORAL SUS
AI Contract Breakdown
Uniform Contract FormatNo documents to break down
The breakdown needs solicitation documents. None were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
